Korean J Intern Med.
1999 Jul;14(2):9-14.
Effect of eradication of Helicobacter pylori on the benign gastric ulcer
recurrence - a 24 month follow-up study
- Affiliations
-
- 1Department of Internal Medicine, Kangnam General Hospital, Public Corporation,
Seoul, Korea.
Abstract
OBJECTIVES
To evaluate the effect of eradication of Helicobacter pylori (H.
pylori) on the recurrence of benign gastric ulcer (BGU) in the patients with
BGU. METHODS: This study was performed for 40 H. pylori-positive BGU patients
cured of BGU and H. pylori eradicated, and for 25 H. pylori-positive patients
(non-eradicated group) who were not treated with H. pylori eradication regimen
or H. pylori was not eradicated. Four different methods--CLOtest, microscopy of
Gram stained mucosal smear, culture and histology of modified Giemsa
staining--were taken for identifying colonization of H. pylori before treatment,
and 4 weeks after completion of triple therapy. For the control group in which
triple therapy was not tried, follow-up gastroscopy was done to confirm the
healing of the ulcer. To detect BGU recurrence, the gastroscopy was performed at
6, 12, 18, and 24 months after therapy. RESULTS: In the non-eradicated group,
the BGU recurrence rate was 16% within 6 months, 40% within 1 year, 56% within
18 months and 60% within 2 years. The respective recurrence rates in the 40
patients in whom the bacteria had been eradicated were 0%, 7.5%, 10% and 10% (4
patients), respectively. Among the four BGU-recurred patients in whom H. pylori
had been eradicated, one patient was found to have BGU recurring with H. pylori
positive again in one year, and another two patients had NSAIDs ingestion
history. CONCLUSION: The eradication of H. pylori in patients with BGU reduces
the recurrence of BGU. In addition, the major causes of BGU recurrence look like
NSAIDs ingestion and reinfection of H. pylori.